Anavex Life Sciences (AVXL) to Release Earnings on Thursday

Anavex Life Sciences (NASDAQ:AVXL) is scheduled to be releasing its earnings data before the market opens on Thursday, May 9th. Analysts expect Anavex Life Sciences to post earnings of ($0.13) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Anavex Life Sciences (NASDAQ:AVXL) last released its quarterly earnings results on Wednesday, February 7th. The biotechnology company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.04. On average, analysts expect Anavex Life Sciences to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Anavex Life Sciences Stock Up 1.6 %

Anavex Life Sciences stock traded up $0.06 during midday trading on Tuesday, hitting $3.90. 200,331 shares of the stock were exchanged, compared to its average volume of 1,388,260. Anavex Life Sciences has a 52-week low of $3.25 and a 52-week high of $10.45. The business’s 50-day moving average price is $4.54 and its 200-day moving average price is $5.90.

Insider Buying and Selling

In other Anavex Life Sciences news, CEO Christopher U. Missling sold 73,380 shares of the business’s stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $5.11, for a total value of $374,971.80. Following the transaction, the chief executive officer now directly owns 1,250,210 shares in the company, valued at $6,388,573.10. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 11.60% of the stock is owned by corporate insiders.

About Anavex Life Sciences

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome.